Related Experiment Video

Updated: Mar 8, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K

Pregnancy heartburn drugs linked to childhood asthma

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |February 2, 2017
    PubMed

    Insights

    Maternal use of acid reflux medication during pregnancy may increase a child's risk of developing asthma. This finding highlights potential prenatal factors influencing pediatric respiratory health.

    Area of Science:

    • Perinatal medicine
    • Pediatric pulmonology
    • Pharmacoepidemiology

    Background:

    • Gastroesophageal reflux disease (GERD) is common during pregnancy.
    • Medications for acid reflux are frequently used by pregnant individuals.
    • Asthma is a prevalent chronic respiratory condition in childhood.

    Purpose of the Study:

    • To investigate the association between maternal acid reflux medication use during pregnancy and the subsequent development of asthma in offspring.
    • To evaluate potential risks linked to specific classes of acid reflux medications.
    • To inform clinical guidelines on medication use during pregnancy.

    Main Methods:

    • Retrospective cohort study design.
    • Utilized large-scale population-based health records.
    • Analyzed data on medication prescriptions and asthma diagnoses in children.

    Main Results:

    • Children born to mothers who took acid reflux medication during pregnancy showed a statistically significant increased risk of developing asthma.
    • The association remained consistent across various analyses, adjusting for potential confounders.
    • Specific medication types may be associated with varying levels of risk.

    Conclusions:

    • Maternal use of acid reflux medication during pregnancy is associated with an elevated risk of childhood asthma.
    • Further research is warranted to elucidate the underlying biological mechanisms.
    • This study suggests a need for careful consideration of acid reflux treatment options during pregnancy.

    More Related Videos

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    32.6K
    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

    Published on: August 25, 2014

    88.2K

    Related Concept Videos

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

    Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
    Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
    1.4K
    Asthma-I: Introduction01:29

    Asthma-I: Introduction

    Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
    3.6K
    Antiasthma Drugs: Leukotriene Modifiers01:19

    Antiasthma Drugs: Leukotriene Modifiers

    Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
    Leukotriene modifiers work through two distinct mechanisms:
    2.1K
    Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

    Antiasthma Drugs: β2-Adrenoceptor Agonists

    Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
    One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
    1.9K
    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

    Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
    Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
    2.1K
    Antiasthma Drugs: Methylxanthines01:24

    Antiasthma Drugs: Methylxanthines

    Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
    Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
    1.9K